← FDA DRUG APPROVALS

FDA ANDA · ANDA075837

FLOXURIDINE

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA075837
TYPE
ANDA
ORIGINAL APPROVAL
2001-02-22
LATEST ACTION
2002-12-05
ROUTE
INTRA-ARTERIAL, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

FLOXURIDINEPrescription
FLOXURIDINE 500MG/VIAL · INJECTABLE · INJECTION

Approval history

2002-12-05Manufacturing (CMC) · Supplement 4AP
2002-11-26Manufacturing (CMC) · Supplement 2AP
2002-11-26Manufacturing (CMC) · Supplement 3AP
2002-11-26Manufacturing (CMC) · Supplement 1AP
2001-02-22OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →